CDK16 and cancer: Of note, USP9X (log2FC/FDR = −0.31/1.7e-06), a previously reported cancer driver, TXLNG (−0.54/3.3e-17), OFD1, MED14, and CDK16 are known to evade X-inactivation and were over-expressed in females’ GC.